MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Health / Surgery
Written by / Agency / Source: PMR Corporate
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Central European Governments Reduce Pharmaceutical Spending Finds PMRCorporate - Several Central European countries are changing their policies on pharmaceutical reimbursements, which may have far reaching effects, especially in the market segments of generic and innovative drugs during the period from 2012-2014 - PMRCorporate.com
Central European Governments Reduce Pharmaceutical Spending Finds PMRCorporate

 

NewswireToday - /newswire/ - Cracow, Malopolskie, Poland, 2012/04/19 - Several Central European countries are changing their policies on pharmaceutical reimbursements, which may have far reaching effects, especially in the market segments of generic and innovative drugs during the period from 2012-2014 - PMRCorporate.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Top manufacturers and distributors are searching for concrete details on the markets in Poland, Romania, Slovakia, the Czech Republic, Hungary and Bulgaria. They need comprehensive market analysis and forecasts to guide them in planning and strategic development in order to adapt to changing pricing, demand and growth prospects in the months ahead.

To meet industry requirements, PMR has compiled Generic and innovative drugs market in Central Europe 2012, Comparative analysis, reimbursement policies and development forecasts for 2012-2014, a new, all-inclusive guide to the regulatory framework and market demands of the region.

“Governments in several Central European countries have recently introduced solutions aimed at cutting their spending on pharmaceuticals. Examples of this are the Reimbursement Act in Poland, the structural reform programme based on the Szell Kalman Plan in Hungary, the amendment to the Act on Public Health Insurance in the Czech Republic and the act governing the scope and conditions of the reimbursement of drugs, medical appliances and dietary foods covered by public health insurance in Slovakia. These will have an impact on the generic and innovative drug segments in the countries in question and may lead to a rebalancing of power and influence within the pharmaceutical segments of each country.”

In order to locate and capitalize on new opportunities, you need direct access to the latest news, sharpest analysis, most reliable statistics and knowledgeable trends forecasting available. Read Generic and innovative drugs market in Central Europe 2012, Comparative analysis, reimbursement policies and development forecasts for 2012-2014 today, and refer to this new report from PMR on a regular basis as you monitor market expansion and contemplate new business strategies.

This market study delivers an overall assessment as well as data on size, value and share of each of these two segments in the covered countries. It details the specific regulatory policies in each of the countries and analyses the changes that will result from new pricing, reimbursement structures, expiry of drug patent procedures and data exclusivity periods. It synthesizes this new information to provide comparative analysis and produce detailed forecasts for the coming two years for market development, guiding professionals in their efforts to keep strategic planning in line with the shifting market.

Data includes pricing regulations for both reimbursed and non-reimbursed medications, VAT rates, reimbursement list changes, best selling products in the generic and innovative drug categories, and an inside look at the opinions of doctors and patients with regard to use of these products. Corporate profiles of the top generic and innovative drug manufacturers and producers in each country and for the region are presented.

The expansive scope of this document also includes the counterfeit drugs sub-segment, its market share and the policies of each government in dealing with the issue.

While preparing Generic and innovative drugs market in Central Europe 2012, Comparative analysis, reimbursement policies and development forecasts for 2012-2014, PMR’s expert analysts have consulted their most reliable sources and created a market guide that answers the questions of readers on all major issues with regard to both the current status and future progression of this dynamic marketplace.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: PMR Corporate

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health / Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Central European Governments Reduce Pharmaceutical Spending Finds PMRCorporate

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: PMRCorporate.com 
+48 12 618 90 00 marketing[.]pmrcorporate.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any PMR Corporate securities in any jurisdiction including any other companies listed or named in this release.

Health / Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From PMR Corporate / Company Profile


Read Health / Surgery Most Recent Related Newswires:

NEC Solution Innovators Establishes 'FonesLife,' A Healthcare Business Company that Contributes to Extending Healthy Life Expectancy
Frost & Sullivan Recognizes DrFirst for Solutions Providing Secure Communication, Collaboration, and Real-Time Access to Patient
The American Psychiatric Association Selects Wiley to Publish its Open Access Journal Psychiatric Research and Clinical Practice
South Carolina Launches Emergency Supply Portal to Connect Providers with Organizations in Need
EHR Investments Increase as Governments and Healthcare Authorities Focus on Interoperability Finds Frost & Sullivan
South Carolina’s Humimic Medical Arming Healthcare Workers for the COVID-19 War
SCBIO Executive Erin Ford Appointed to South Carolina District Export Council for 2020-2021
University of the Ryukyus and NEC Discover a Novel Diagnostic Biomarker for Acute Adult T-cell Leukemia/lymphoma
Change Healthcare Recognized by Frost & Sullivan for Accelerating Claims Processing with its Intelligent Healthcare Network™ Blockchain Technology
SCBIO CEO Sam Konduros Named to South Carolina Chamber Executive Committee
Frost & Sullivan Defines Top Femtech Global Opportunities by 2024
Frost & Sullivan Highlights on Impact of the Coronavirus on Business
Global Healthcare to Soar Above Trillion in 2020 with Consumerism and Outcome-based Care Models Finds Frost & Sullivan
Demand for CROs Rises to Strike Evolving Clinical Trial Models for Target Therapies Reports Frost & Sullivan
PointClickCare Integrated Care Coordination Platform Applauded by Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  JobsWare.com





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)